Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Active, Not Recruiting

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

NCT06331299

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • The George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Peachtree Clinical Solutions Powder Springs, Georgia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Hospital Universitario Austral Buenos Aires, Argentina
  • Lucen S.A. Buenos Aires, Argentina
  • Consultorio Privado Korbenfeld CABA, Argentina
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
View all 258 locations
View Trial Details
Active, Not Recruiting

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

NCT02989584

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

NCT06129084

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • Arthur J.E Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details

Related conditions